Product Information
METHOTREXATE 250 MG/10 ML VIAL is a generic product labeled by Teva Parenteral Medicines, Inc., priced at $0.7327 per ML under NDC 00703367501. Its NADAC has been published 470 times since Nov 28, 2013.
Strength
25 mg/mL
Manufacturer
Teva Parenteral Medicines, Inc.NDC
00703367501
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS
Last Updated
6/17/2026
Active Ingredients
METHOTREXATE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA040843On Market Since
8/1/2012
Pharmacological Classes
Price Statistics
The NADAC for METHOTREXATE 250 MG/10 ML VIAL has been published 470 times since Nov 28, 2013, and over the history we have for it it has declined 50.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7327 per ML |
|---|---|
| All-time high | $1.4874 (Dec 11, 2013) |
| All-time low | $0.6670 (Sep 21, 2016) |
| 52-week high | $0.8206 |
| 52-week low | $0.7082 |
| Median price | $0.7998 |
| Average price | $0.7864 |
| Largest weekly change | -45.7% (Dec 18, 2013) |
| Weeks tracked | 470 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 12% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METHOTREXATE 250 MG/10 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for METHOTREXATE 250 MG/10 ML VIAL, manufactured by Teva Parenteral Medicines, Inc., is $0.7327 per ML (NDC 00703367501), effective Jun 24, 2026.
How has the price of METHOTREXATE 250 MG/10 ML VIAL changed over time?
Over the history we have for it, the NADAC for METHOTREXATE 250 MG/10 ML VIAL has declined 50.7%. It has been tracked across 470 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for METHOTREXATE 250 MG/10 ML VIAL?
Since Nov 28, 2013, the NADAC for METHOTREXATE 250 MG/10 ML VIAL has ranged from a low of $0.6670 (Sep 21, 2016) to a high of $1.4874 (Dec 11, 2013), with a median of $0.7998 per ML.
Are there cheaper alternatives to METHOTREXATE 250 MG/10 ML VIAL?
Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, METHOTREXATE 1 GRAM/40 ML VIAL, is $0.6450 per ML — about 12% below METHOTREXATE 250 MG/10 ML VIAL.
Who manufactures METHOTREXATE 250 MG/10 ML VIAL?
METHOTREXATE 250 MG/10 ML VIAL (NDC 00703367501) is labeled by Teva Parenteral Medicines, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification